Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue
+0.15%
EPS
+342.0%
Free cash flow
+220.1%
Total debt
−39.4%

Quarter to September 2026, against a year earlier

151.46 0.69 −0.45%
Market cap
$6.5B
P/E
18.2×
Fwd P/E
37.4×
Dividend yield
0.90%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 15.04
P/S ratio
2.73 2.49 2.45 2.30
P/FCF ratio
3,766.02 29.65 103.95 36.34
P/Operating CF
(147.10) 113.45 60.09 53.88
P/B ratio
1.74 1.72 1.90 1.79
EV/Sales
3.87 3.57 3.56 2.83
EV/EBITDA
25.63 29.13 31.34 24.89
EV/FCF
5,330.95 42.57 151.15 44.67
Current Ratio
2.54 2.55 2.60 2.01
Net Debt/EBITDA
(30.04) 30.61 20.20 0.00
Debt/Equity
0.85 0.85 0.97 0.46
Earnings Yield
(16.83%) (19.06%) (18.37%) 6.65%
Free Cash Flow Yield
0.03% 3.37% 0.96% 2.75%
Free Cash Flow per Share
(0.01) 0.63 1.79 1.80
Book value per Share
70.03 69.69 66.68 84.22
Free Cash Flow
(0.65) 27.87 77.86 74.66
EV/EBIT
65.12 121.13 180.68 11.41
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026